Taking piroxicam, an anti-inflammatory medication commonly used for arthritis pain, at the same time as the levonorgestrel emergency contraceptive pill after unprotected sex prevents significantly more pregnancies compared ...
Aug 16, 2023
0
59
Curbing levels of harmful air pollution could help reduce antibiotic resistance, according to the first in-depth global analysis of possible links between the two, published in The Lancet Planetary Health journal.
Aug 7, 2023
0
3
An interim safety analysis of the first randomized controlled trial of its kind involving over 80,000 Swedish women published in The Lancet Oncology journal, finds artificial intelligence (AI)-supported mammography analysis ...
Aug 1, 2023
0
31
People living with HIV who maintain low—but still detectible—levels of the virus and adhere to their antiretroviral regimen have almost zero risk of transmitting it to their sexual partners, according to an analysis published ...
Jul 29, 2023
0
19
The findings of the first randomized controlled trial (RCT) of its kind involving nearly 1,000 older adults from multiple locations across the U.S., published in The Lancet, add to the growing evidence that addressing hearing ...
Jul 18, 2023
0
64
Commercial, rather than patient interests, often drive cancer care and research and patients deserve better, argue a group of global oncologists and patient advocates in a Comment published in The Lancet Oncology journal. ...
Jul 17, 2023
0
1
People in their eighties who can recall everyday events and life experiences as well as someone 20 to 30 years younger—known as superagers—are also more likely to have greater movement speed than typical older adults. ...
Jul 13, 2023
0
191
Reducing the burden of sickle cell disease (SCD) requires substantial financial and political commitment to improving dataccollection, diagnosis, treatment and training. Doing so will positively impact the lives of millions ...
Jul 13, 2023
0
1
The VLA1553 vaccine candidate for chikungunya disease was generally well tolerated and produced an immune response in 99% (263/266) of participants, according to a phase 3 randomized controlled trial published in The Lancet.
Jun 12, 2023
0
40
Taking a two-week course of metformin, a safe and affordable diabetes medication after testing positive for SARS-CoV-2 leads to 40% fewer long COVID diagnoses over the following 10 months, compared to individuals taking a ...
Jun 8, 2023
0
251
